Enantioselective Synthesis of ε‐Lactams via Rh(I)‐Catalyzed C─C Bond Activation

S Shiyuan Sui (State Key Laboratory of Antiviral Drugs NMPA Key Laboratory for Research and Evaluation of Innovative Drug School of Chemistry and Chemical Engineering Pingyuan Laboratory Henan Normal University Xinxiang 453007 China) H Hao Wu Y Yuanyuan Guo G Gongming Chen (State Key Laboratory of Antiviral Drugs NMPA Key Laboratory for Research and Evaluation of Innovative Drug School of Chemistry and Chemical Engineering Pingyuan Laboratory Henan Normal University Xinxiang 453007 China) J Junbiao Chang D Dachang Bai (State Key Laboratory of Antiviral Drugs NMPA Key Laboratory for Research and Evaluation of Innovative Drug School of Chemistry and Chemical Engineering Pingyuan Laboratory Henan Normal University Xinxiang 453007 P.R. China)

Abstract

Abstract ε‐Lactams are important structural motifs in medicinal chemistry, but a fully enantioselective synthesis without byproduct formation represents a challenge that has attracted significant research interest. Herein, we report an atom‐ and step‐economic synthesis of chiral ε‐lactams via Rh(I)‐catalyzed enantioselective C─C bond activation of aminocyclopropanes. The catalytic C─C bond activation enables a directed generation of chiral rhodacyclobutanes that circumvents β‐hydride decomposition. Subsequent enantioselective cycloaddition of the alkene unit and then fragmentation generates chiral ε‐lactams. A range of enantioenriched ε‐lactams have been obtained with excellent regio‐ and enantioselectivities, which can undergo several stereospecific transformations. Theoretical calculations are performed to reveal the reaction mechanism and the origin of enantioselectivity control.

Article Details

Volume / Issue Vol. 64, Issue 37
Published September 08, 2025
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (6)

S

Shiyuan Sui

State Key Laboratory of Antiviral Drugs NMPA Key Laboratory for Research and Evaluation of Innovative Drug School of Chemistry and Chemical Engineering Pingyuan Laboratory Henan Normal University Xinxiang 453007 China

H

Hao Wu

Y

Yuanyuan Guo

G

Gongming Chen

State Key Laboratory of Antiviral Drugs NMPA Key Laboratory for Research and Evaluation of Innovative Drug School of Chemistry and Chemical Engineering Pingyuan Laboratory Henan Normal University Xinxiang 453007 China

J

Junbiao Chang

D

Dachang Bai

State Key Laboratory of Antiviral Drugs NMPA Key Laboratory for Research and Evaluation of Innovative Drug School of Chemistry and Chemical Engineering Pingyuan Laboratory Henan Normal University Xinxiang 453007 P.R. China